title: Cardioprotective effects of glycyrrhizic acid against isoproterenol-induced myocardial ischemia in rats.
abstract: The aim of the present study was to look into the possible protective effects of glycyrrhizic acid (GA) against isoproterenol-induced acute myocardial infarction in Sprague-Dawley rats. The effect of three doses of glycyrrhizic acid in response to isoproterenol (ISO)-induced changes in 8-isoprostane, lipid hydroperoxides, super oxide dismutase and total glutathione were evaluated. Male Sprague-Dawley rats were divided into control, ISO-control, glycyrrhizic acid alone (in three doses-5, 10 and 20 mg/kg BW) and ISO with glycyrrhizic acid (in three doses) groups. ISO was administered at 85 mg/kg BW at two consecutive days and glycyrrhizic acid was administered intraperitoneally for 14 days. There was a significant increase in 8-isoprostane (IP) and lipid hydroperoxide (LPO) level in ISO-control group. A significant decrease in total superoxide dismutase (SOD) and total glutathione (GSH) was seen with ISO-induced acute myocardial infarction. Treatment with GA significantly increased SOD and GSH levels and decreased myocardial LPO and IP levels. Histopathologically, severe myocardial necrosis and nuclear pyknosis and hypertrophy were seen in ISO-control group, which was significantly reduced with GA treatment. Gycyrrhizic acid treatment proved to be effective against isoproterenol-induced acute myocardial infarction in rats and GA acts as a powerful antioxidant and reduces the myocardial lipid hydroperoxide and 8-isoprostane level.
authors.affiliation: Human Biology Division, School of Medicine, International Medical University, Kuala Lumpur 57000, Malaysia.
authors.forename: Nagaraja
authors.initials: N
authors.lastname: Haleagrahara
authors.forename: Julian
authors.initials: J
authors.lastname: Varkkey
authors.forename: Srikumar
authors.initials: S
authors.lastname: Chakravarthi
mesh_terms: D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015237:Dinoprost / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D019695:Glycyrrhizic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D007545:Isoproterenol / Q000633:toxicity; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D017202:Myocardial Ischemia / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D002316:Cardiotonic Agents; C075750:8-epi-prostaglandin F2alpha; D019695:Glycyrrhizic Acid; D015237:Dinoprost; D013482:Superoxide Dismutase; D005978:Glutathione; D007545:Isoproterenol
references.citation: Biol Pharm Bull. 2007 Oct;30(10):1898-904
references.pmid: 17917259
references.citation: Circulation. 1990 Jan;81(1):201-11
references.pmid: 2297827
references.citation: Biochem J. 2009 Jul 15;421(3):473-82
references.pmid: 19442240
references.citation: J Am Coll Cardiol. 2007 Nov 27;50(22):2173-95
references.pmid: 18036459
references.citation: Nat Med. 1998 Nov;4(11):1241-3
references.pmid: 9809543
references.citation: Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1366-72
references.pmid: 15937102
references.citation: Mol Cell Biochem. 2001 Sep;225(1-):75-83
references.pmid: 11716367
references.citation: Am J Med. 2000 Sep;109(4):315-23
references.pmid: 10996583
references.citation: Antiviral Res. 1988 Dec 11;10(6):289-98
references.pmid: 3250333
references.citation: Clin Chem. 1987 Aug;33(8):1419-20
references.pmid: 3608159
references.citation: Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22
references.pmid: 8367443
references.citation: Exp Physiol. 1997 Mar;82(2):291-5
references.pmid: 9129943
references.citation: Planta Med. 1991 Apr;57(2):119-21
references.pmid: 1891493
references.citation: Indian J Exp Biol. 2004 Feb;42(2):174-8
references.pmid: 15282950
references.citation: J Ethnopharmacol. 2004 Sep;94(1):155-8
references.pmid: 15261977
references.citation: Clin Chem. 2004 Nov;50(11):2205-13
references.pmid: 15502101
references.citation: Circulation. 2001 Jul 17;104(3):365-72
references.pmid: 11457759
references.citation: Cardiovasc Res. 1998 Jan;37(1):91-100
references.pmid: 9539862
references.citation: Toxicology. 2006 Dec 7;228(2-3):259-68
references.pmid: 17084010
references.citation: Pharmacology. 2009;84(1):29-37
references.pmid: 19494560
references.citation: Eur J Pharmacol. 2009 Aug 1;615(1-3):125-32
references.pmid: 19445921
references.citation: Pharmacol Res. 1998 Oct;38(4):297-303
references.pmid: 9774493
references.citation: Int J Cardiol. 2008 May 7;126(1):123-6
references.pmid: 17467089
references.citation: Eur J Pharmacol. 2008 May 31;586(1-3):244-50
references.pmid: 18384769
references.citation: Biochem Pharmacol. 1996 Jan 12;51(1):1-9
references.pmid: 8534261
references.citation: Indian J Clin Biochem. 2007 Mar;22(1):10-7
references.pmid: 23105645
references.citation: Int J Biochem. 1982;14(7):649-53
references.pmid: 7106362
references.citation: Intensive Care Med. 2009 Apr;35(4):687-97
references.pmid: 18953525
references.citation: Plant Foods Hum Nutr. 2009 Mar;64(1):75-80
references.pmid: 19058010
references.citation: Comp Biochem Physiol C Toxicol Pharmacol. 2003 Dec;136(4):377-86
references.pmid: 15012909
references.citation: Clin Chem. 1998 Aug;44(8 Pt 2):1855-64
references.pmid: 9702995
references.citation: Basic Clin Pharmacol Toxicol. 2007 Apr;100(4):233-9
references.pmid: 17371527
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10721-5
references.pmid: 1438268
references.citation: Thorax. 2000 Mar;55(3):205-9
references.pmid: 10679539
references.citation: Exp Toxicol Pathol. 2008 Aug;60(4-5):397-404
references.pmid: 18513933
references.citation: Mol Cell Biochem. 2003 Jan;243(1-2):133-8
references.pmid: 12619898